AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California. Show More...
-
Website http://www.acelrx.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 1.13 USD
-
Last Updated 12-03-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.74 -1.16 -1.51 -0.59 -0.91 -0.6 -0.95 -1.1 -0.81 -0.67 -0.7 Dividends USD Payout Ratio % * Shares Mil 19.0 17.0 22.0 40.0 44.0 44.0 45.0 47.0 58.0 79.0 80.0 Book Value Per Share * USD 1.19 0.91 1.24 1.35 0.88 0.07 -0.6 -0.48 -0.36 -0.68 Free Cash Flow Per Share * USD -1.13 -1.15 -0.94 -0.15 -0.85 -0.32 -0.83 -0.51 -0.64 Return on Assets % -134.55 -84.34 -63.33 -26.84 -33.95 -22.78 -37.89 -58.68 -48.09 -50.25 -58.17 Financial Leverage (Average) 2.34 1.91 1.5 1.85 3.86 28.34 Return on Equity % -130.03 -43.78 -55.67 -61.17 -310.75 Return on Invested Capital % -68.81 -10.26 -45.38 -35.33 -90.91 Interest Coverage -8.72 -8.38 -13.61 -0.4 -11.64 -3.37 -2.55 -2.72 -2.75 -43.44 -410.02 Current Ratio 0.43 4.86 4.31 15.22 5.56 9.31 8.74 4.64 6.78 5.27 3.69 Quick Ratio 0.27 4.56 4.17 15.09 5.49 9.14 8.45 4.54 6.66 4.9 3.39 Debt/Equity 0.87 0.25 0.2 0.39 0.49 0.79